Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-A randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events

The JPPP is the largest primary prevention trial of aspirin in a Japanese population that is investigating whether the benefit of aspirin in reducing risk of vascular events outweighs any bleeding risk in elderly patients with multiple risk factors.